MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RIGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rigel Pharmaceuticals (RIGL) Earnings Date & Reports

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

RIGL is expected to report earnings to rise 32.95% to $1.17 per share on November 10

Rigel Pharmaceuticals RIGL Stock Earnings Reports
Q3'26
Est.
$1.17
Q2'26
Beat
by $0.67
Q1'26
Beat
by $0.58
Q4'25
Beat
by $13.52
Q3'25
Beat
by $1.45
The last earnings report on August 04 showed earnings per share of 87 cents, beating the estimate of 20 cents. With 136.65K shares outstanding, the current market capitalization sits at 761.58M.
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Trend Trader for RUSSELL 2000: Magic Formula & Optimal Structure, 60min, (FA)Trend Trader for RUSSELL 2000: Magic Formula & Optimal Structure, 60min, (FA)
Annualized Return+16%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
RIGL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for RIGL
A.I. Advisor
published General Information

General Information

a clinical-stage drug development company that discovers and develops novel, small-molecule drugs

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
174
Web
https://www.rigel.com